Weekly updateCompaniesRecruiting servicePost a job
Imago BioSciences

Imago BioSciences

    Company info:

  • 1-50
  • 2012
  • San Francisco, CA
  • 100-500M



Claim company profile

About company:

Imago Biosciences is developing treatments for patients with life-threatening diseases of the bone marrow. Lysine-specific demethylase 1 (LSD1) is a protein that plays a key role in the behavior of malignant blood cells by influencing which genes are expressed. Imago focuses on studying the activity of LSD1, which they believe offers the greatest chance of treating bone marrow diseases since LSD1 plays a unique role in each step of blood cell formation. This includes the discovery and development of identifying small molecule inhibitors and degraders of LSD1. Imago’s lead product, bomedemstat, is an orally available inhibitor of LSD1 that is currently being tested in clinical trials for patients with myeloproliferative neoplasms.


Claim company profile to post jobs directly on this page and this website.

© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com